Results 251 to 260 of about 114,909 (286)

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Lancet Infectious Diseases, The, 2021
Matteo Bassetti, Mari Ariyasu, Yohei Doi
exaly  

Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae

Nature Medicine, 2020
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio   +2 more
exaly  

Carbapeneme

2006
Manfred Fille, Johann Hausdorfer, Manfred P. Dierich, Klaus Miksits   +3 more
openaire   +1 more source

Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients

Nature Microbiology, 2021
Ricardo León-Sampedro, Javier DelaFuente, Thomas Crellen   +2 more
exaly  

Carbapenems

2016
openaire   +2 more sources

Carbapenems

2011
Robert W. Finberg, Roy Guharoy
openaire   +1 more source

Regulation and biosynthesis of carbapenem antibiotics in bacteria

Nature Reviews Microbiology, 2005
Sarah J Coulthurst, George P C Salmond
exaly  

Carbapenem resistance

2020
Indranil Samanta, Samiran Bandyopadhyay
openaire   +1 more source

Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread

Nature Microbiology, 2019
Sophia David, Sandra Reuter, Corinna Glasner   +2 more
exaly  

The rapid spread of carbapenem-resistant Enterobacteriaceae

Drug Resistance Updates, 2016
Alaric W D'souza, Gautam Dantas
exaly